Mefenorex
Clinical data | |
---|---|
ATC code | A08AA09 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 17243-57-1 Y |
PubChem (CID) | 21777 |
ChemSpider | 20467 Y |
UNII | K98M4N387W Y |
KEGG | D07891 Y |
ECHA InfoCard | 100.037.511 |
Chemical and physical data | |
Formula | C12H18ClN |
Molar mass | 211.731 |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Mefenorex (Rondimen, Pondinil, Anexate) is a stimulant drug which was used as an appetite suppressant. It is an amphetamine derivative which was developed in the 1970s and used for the treatment of obesity.[1][2] Mefenorex produces amphetamine as a metabolite,[3] and has been withdrawn in many countries despite having only mild stimulant effects and relatively little abuse potential.[4]
References
- ↑ Vincendeau MJ. A new regulator of appetite: mefenorex. (French). Bordeaux Medical. 1970 Jul-Aug;3(7):1951-3.
- ↑ Beyer G, Huth K, Muller GM, Niemoller H, Raisp I, Vorberg G. The treatment of obesity with the appetite curbing agent Mefenorex. (German). Die Medizinische Welt. 1980 Feb;31(8):306-9.
- ↑ Rendic S, Slavica M, Medic-Saric M. Urinary excretion and metabolism of orally administered mefenorex. European Journal of Drug Metabolism and Pharmacokinetics. 1994 Apr-Jun;19(2):107-17.
- ↑ Engel J, Kristen G, Schaefer A, von Schlichtegroll A. Mefenorex (Rondimen). Drug and Alcohol Dependence. 1986 Jun;17(2-3):229-34.
α1 |
| ||||||
---|---|---|---|---|---|---|---|
α2 |
| ||||||
β |
| ||||||
|
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
This article is issued from Wikipedia - version of the 9/5/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.